Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fAMHOPE: Ovarian Stimulation in Breast Cancer
NCT04289805Phase 4Terminated
- Sponsor
- Erasmus Hospital
- Start
- Feb 2019
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 4 trial of letrozole in breast cancer, sponsored by Erasmus Hospital. Started Feb 2019; status: terminated.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04289805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04289805.